The market is far too pessimistic on GlaxoSmithKline
Surprisingly shares in pharmaceutical company GlaxoSmithKline (GSK) are trading below their March lows and have underperformed European and US peers by 18% year-to-date.The shares trade on a PE (price-to-earnings) of 11.4, roughly...
05 November 2020